Seeking Alpha

Pozen (POZN +21.2%) shares spike after the FDA approves its new Vimovo arthritis medication...

Pozen (POZN +21.2%) shares spike after the FDA approves its new Vimovo arthritis medication co-developed with AstraZeneca (AZN +0.3%).
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|